High payload delivery of optical imaging and photodynamic therapy agents to tumors using phthalocyanine-reconstituted low-density lipoprotein nanoparticles.
To improve the labeling efficiency of a low-density lipoprotein (LDL)-based photosensitizer (PS) for achieving high probe to protein payload, a tetra-t-butyl silicon phthalocyanine bearing two oleate moieties at its axial positions, SiPcBOA, is designed and synthesized. Using this novel strategy, SiPcBOA reconstituted LDL (r-SiPcBOA-LDL) with a very high payload (SiPcBOA to LDL molar ratio >3000 to 35001:1) is obtained. Using electron microscopy, we find reconstituted LDL (rLDL) with such a high payload essentially retains the mean particle size of native LDL. Since acetylated LDL binds to scavenger receptors of endothelial and microglial cells instead of LDLR, SiPcBOA reconstituted acetylated LDL (r-SiPcBOA-AcLDL) is also prepared to serve as a negative control to validate the LDL receptor (LDLR) targeting specificity. Confocal microscopy studies demonstrate that the internalization of r-SiPcBOA-LDL by human hepatoblastoma G2 (HepG2) tumor cells is mediated by LDLR pathway. The in vitro photodynamic therapy (PDT) response of HepG2 cells to r-SiPcBOA-LDL is compared to SiPcBOA (free drug control) using a clonogenic assay. The slopes of the linear regression fit to the logarithmic data for these two plots are significantly different from each other (p=0.0007), indicating greatly enhanced efficacy of LDLR-targeted PDT.
Li
Hui
H
University of Pennsylvania, Department of Radiology, Philadelphia, Pennsylvania 19104, USA.
Marotta
Diane E
DE
Kim
Soungkyoo
S
Busch
Theresa M
TM
Wileyto
E Paul
EP
Zheng
Gang
G
D045744:Cell Line, Tumor; D016503:Drug Delivery Systems / Q000379:methods*; D018197:Hepatoblastoma / Q000188:drug therapy* / Q000473:pathology*; D006801:Humans; D007211:Indoles / Q000737:chemistry / Q000627:therapeutic use*; D054833:Isoindoles; D008077:Lipoproteins, LDL / Q000737:chemistry / Q000627:therapeutic use*; D008113:Liver Neoplasms / Q000188:drug therapy / Q000473:pathology; D008856:Microscopy, Fluorescence / Q000379:methods*; D043942:Nanotubes / Q000737:chemistry; D010778:Photochemotherapy / Q000379:methods*; D017319:Photosensitizing Agents / Q000737:chemistry / Q000627:therapeutic use
D007211:Indoles; D054833:Isoindoles; D008077:Lipoproteins, LDL; D017319:Photosensitizing Agents; C013647:phthalocyanine